Equities

Grand Pharmaceutical Group Ltd

Grand Pharmaceutical Group Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income2,3442,5172,786
Depreciation/depletion363363322
Non-Cash items283173(544)
Cash taxes paid, supplemental471349277
Cash interest paid, supplemental20413793
Changes in working capital(594)(1242)(576)
Total cash from operations2,4251,8432,006
INVESTING
Capital expenditures(498)(1085)(536)
Other investing and cash flow items, total(18)(1275)(1233)
Total cash from investing(516)(2360)(1769)
FINANCING
Financing cash flow items(230)(145)(159)
Total cash dividends paid(497)(390)(390)
Issuance (retirement) of stock, net(81)(44)(144)
Issuance (retirement) of debt, net(1081)906360
Total cash from financing(1889)327(333)
NET CHANGE IN CASH
Foreign exchange effects(124)(118)13
Net change in cash(104)(309)(84)
Net cash-begin balance/reserved for future use1,4441,7531,837
Net cash-end balance/reserved for future use1,3401,4441,753
SUPPLEMENTAL INCOME
Depreciation, supplemental363363322
Cash interest paid, supplemental20413793
Cash taxes paid, supplemental471349277
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.